Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Physio-Control's Lifepak 12 Stimulates Wall Street - Stock Up 31% In April

This article was originally published in The Gray Sheet

Executive Summary

Physio-Control's release of higher than anticipated first-quarter results April 20, driven by strong initial demand for the firm's recently introduced Lifepak 12 external defibrillator/monitor, translated into a stock price increase of 31.4% for the month. The issue closed April at 23 after gaining 5-1/2 points.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts